Arrowhead Research reported $-72909000 in EBIT for its second fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Ebit Change
Agios Pharmaceuticals AGIO:US $ -97640000 3.5M
Alnylam Pharmaceuticals ALNY:US $ -191686000 44.95M
Anika Therapeutics ANIK:US $ -3381000 173K
Arrowhead Research ARWR:US $ -72909000 114.46M
Bluebird Bio BLUE:US $ -100761000 19.58M
Cerulean Pharma CERU:US $ -8400450 1.14M
Intercept Pharmaceuticals ICPT:US $ -13363000 3.09M
IONIS PHARMACEUT IONS:US $ -85514000 28.01M
Merk MRK:US $ 5711M 652M
Mirati Therapeutics MRTX:US $ -177205000 7.01M
Moderna Inc MRNA:US 2.45B 1.78B
Nektar Therapeutics NKTR:US $ -47713000 67.37M
Novartis NOVN:VX 3.32B 176M
Opko Health OPK:US $ -26104000 46.32M
Sarepta Therapeutics SRPT:US $ -211132000 124.25M
Spectrum Pharmaceuticals SPPI:US $ -25392000 11.33M
Tg Therapeutics TGTX:US $ -38941000 27.93M
Ultragenyx Pharmaceutical RARE:US $ -141593000 4.96M
Vertex Pharmaceuticals VRTX:US $ 1119.3M 85.9M
Xencor XNCR:US $ -28000000 54.47M
YTE INCY:US $ 260.29M 132.62M